- Shop
- Tangential Flow Filtration (TFF)
- Single-use TFF Assemblies
- Sartocon® and Sartocube® | TFF Ultrafiltration | Self-Contained Units | Q-Screen 30 kDa mAb
Sartocube® Self-Contained Unit | Hydrosart® | 30 kDa mAb | 12.36 m²
Sartocon® Q and Sartocube® Q self-contained units are ready-to-use devices for sterile and aseptic processing. Combined with Hydrosart® 30kDa mAb membrane, they enable fast and efficient mAb concentration, coming pre-flushed and sterile, eliminating pre-use preparation.
- Item No.:
- SFM-AQ-14460A2
Sartocon® Q and Sartocube® Q self-contained units are ready-to-use devices for sterile and aseptic processing. Combined with Hydrosart® 30kDa mAb membrane, they enable fast and efficient mAb concentration, coming pre-flushed and sterile, eliminating pre-use preparation.
Overview
Specifications
Choose your Sartocon® and Sartocube® | TFF Ultrafiltration | Self-Contained
Sartocon® Q and Sartocube® Q self-contained units are ready-to-use devices for sterile and aseptic processing. Combined with Hydrosart® 30kDa mAb membrane, they enable fast and efficient mAb concentration.
Advantages
· Delivered pre-flushed, sterile & ready to use
· No CIP and cleaning validation necessary
· Increased flexibility combined with time savings
The new Sartocon® Q Hydrosart® 30 kDa mAb SCU features the new Q screen design for final viscosities between 3-30cP, combined with an mAb optimized 30kDa cut off.
Our Hydrosart® 30kDa membrane is a high-performance, stabilized cellulose-based membrane optimized for monoclonal antibody processing.
· Extremely hydrophilic, ensuring non-protein binding and virtually non-fouling properties.
· Exceptionally cleanable, with high caustic stability, providing a long-life cycle with stable performance in flux and retention.
Typical applications within aseptic processing:
· Concentration of monoclonal antibodies (mAbs)
· Volume reduction of buffer exchange
This new cassette type was specifically optimized for monoclonal antibody applications but is also suitable for molecules of similar size, as well as e.g. bispecific antibodies.
Compliance and quality
Sartorius TFF products comply with global regulatory and quality standards (see specification area) and are tested for integrity during final release.
Sartocon® Q & Sartocube® Q SCU are ideally combined with Sartorius Sartocon® holders and Sartoflow® systems.
Applications
-
IndustryPharma / Biotech
Compliance Information
-
Bacterial Endotoxins< 0.18 EU/mL as determined by the LAL test
-
Biological ReactivityAll materials of this filter element meet the requirements of the current USP Biological Reactivity tests <88> for plastics Class VI (Systemic Injection, Intracutaneous and Implantation tests).
-
ExtractablesThe total amount of extractables is well below the limits established by the current USP unter "Sterile Water for Injection".
Dimensions
-
Channel HeightQ-Screen (Medium viscosity)
-
Filtration Area12.36 m²
-
Flow Channel GeometryViscosity 3–30 cp
General Specifications
-
Cassette FormatSartocube® SCU
-
Filter ClassUltrafilter
Materials of Construction
-
Membrane MaterialHydrosart®
-
Sealing CompoundSilicone Grey
-
SpacerPolysulfone
Operating Conditions
-
Maximum Inlet Pressure4 bar
-
pH StabilitypH 2 - 14
Physicochemical Information
-
MWCO30 kDa mAb
-
Non-Fiber ReleasingThis filter product complies with the title 21 of the Code of Federal Regulations (CFR), section 210.3(b)(6) and 211.72.
Product Information
-
BrandSartocube®
-
Pack Size1